Pfm Health Sciences, LP Iveric Bio, Inc. Transaction History

Pfm Health Sciences, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$18.67 - $24.56 $10.2 Million - $13.5 Million	547,926 Added 59.72%	1,465,483 $35.7 Million
Q4 2022 Feb 14, 2023	BUY	$17.24 - $23.95 $11.4 Million - $15.8 Million	661,273 Added 258.02%	917,557 $19.6 Million
Q3 2022 Nov 14, 2022	SELL	$9.4 - $18.59 $6.11 Million - $12.1 Million	-649,732 Reduced 71.71%	256,284 $4.6 Million
Q2 2022 Aug 15, 2022	SELL	$9.12 - $18.9 $904,703 - $1.87 Million	-99,200 Reduced 9.87%	906,016 $8.72 Million
Q4 2021 Feb 14, 2022	SELL	$13.83 - $18.78 $1.84 Million - $2.5 Million	-132,896 Reduced 11.68%	1,005,216 $16.8 Million
Q3 2021 Nov 15, 2021	BUY	$7.07 - $17.5 $8.05 Million - $19.9 Million	1,138,112 New	1,138,112 $18.5 Million

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

Stay updated on Pfm Health Sciences, LP with notifications on news.